Chemoinformaics analysis of 7-Deoxygelsemide or 9- Deoxygelsemide
| Molecular Weight | 196.202 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 14 |
| Exact Molecular Weight | 196.074 | nRing | 3 |
| Solubility: LogS | -1.26 | nHRing | 2 |
| Solubility: LogP | 0.452 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 27.9095 |
| nHD | 1 | BPOL | 16.3785 |
| QED | 0.557 |
| Synth | 4.931 |
| Natural Product Likeliness | 2.916 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.393 |
| CACO-2 | -4.733 |
| MDCK | 0.0000374 |
| BBB | 0.981 |
| PPB | 0.235052 |
| VDSS | 0.916 |
| FU | 0.694346 |
| CYP1A2-inh | 0.281 |
| CYP1A2-sub | 0.505 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.635 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.154 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.234 |
| CYP3a4-inh | 0.07 |
| CYP3a4-sub | 0.319 |
| CL | 9.011 |
| T12 | 0.606 |
| hERG | 0.024 |
| Ames | 0.298 |
| ROA | 0.691 |
| SkinSen | 0.101 |
| Carcinogencity | 0.932 |
| EI | 0.038 |
| Respiratory | 0.923 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.891635 |